What is the BE CARING Study about?
The aim of the BE CARING Study is to gather information about the amounts of a drug called bimekizumab in the breast milk of breastfeeding mothers who are taking it for an autoimmune or autoinflammatory disease. The study will also assess the amounts of bimekizumab in the blood of both the mother and (optionally, if the parents or guardians agree to it) her breastfeeding baby.